Yes,in KAMC- (Transfusion Medicine Dep't),We do perform ABORH and DAT on ALL cord blood samples routinly.Further Evaluations:The DAT is usually strongly positive in HDN due to anti-D or antibodies in other blood groups;however the reactions may be weak or negative in HDN due to ABO.If the DAT is positive,elute and identify the antibody.Compare its specificity to any antibodies identified in the maternal specimen. If the DAT is positive but the maternal serum is antibody-screen negative,either ABO-HDN or HDN due to a low-incidence antigen should be considered.Perform an eluate from the cord blood and test against A1,B and O cells. Even if the DAT is negative and ABO-HDN is suspected,perform an eluate and test against A1,B and O cells using an antiglobulin technique.If transfusion is required,use group O,RH-compatible cells even if the diagnosis is not serologically confirmed. If ABO-HDN has been ruled out,an antibody against a low incidence antigen should be considered.Perform an eluate from the cord blood and test against the father's cells using an antiglobulin technique.Then test the mother's serum against the paternal cells using an antiglobulin technique. If the DAT is positive and all attempts to characterize it have failed ,consider false positive causes for a DAT(RBC agglutination before washing,cotamination with colloidal silica,improperly cleaned glassware,overcentrifugation,improperly prepared reagent with anti-human species antibodies,cold agglutinins causing complement deposition,silica gel contamination,contamination with IV solutionscontaining dextrose in distilled water,T-activation(polyagglutination)from bacterial sepsis).